Skip to content
  • Sunday, 26 July 2026
  • 2:50 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Ludwig Cancer Research Study Identifies Novel Combination Therapy to Overcome Differentiation Block in Acute Myelogenous Leukemia
Stem Cell & Regenerative Medicine

Ludwig Cancer Research Study Identifies Novel Combination Therapy to Overcome Differentiation Block in Acute Myelogenous Leukemia

Dwi Wanna Jul 3, 2026 0

Acute Myelogenous Leukemia (AML) remains one of the most formidable challenges in modern oncology, characterized by a rapid progression and…

Read More
Stem Cell & Regenerative Medicine

Ludwig Cancer Research Study Identifies Novel Synergistic Combination Therapy to Overcome Differentiation Block in Acute Myelogenous Leukemia

Dwi Wanna Jun 16, 2026 0

The landscape of hematological oncology faces a persistent and formidable challenge in the form of acute myelogenous leukemia (AML), a…

Read More
Neuroscience & Brain Research

Researchers block key protein that helps Parkinson’s spread through the brain

Rifan Muazin May 31, 2026 0

Researchers at the Perelman School of Medicine at the University of Pennsylvania have uncovered a critical biological mechanism that may…

Read More
Stem Cell & Regenerative Medicine

Ludwig Cancer Research Study Identifies Novel Combination Therapy to Overcome Differentiation Block in Acute Myelogenous Leukemia

Dwi Wanna Apr 4, 2026 0

The landscape of hematological oncology is facing a potential paradigm shift following a comprehensive study led by Ludwig Cancer Research,…

Read More
Biotech & Genetic Research

Seaweed shield: marine molecules may block norovirus infection

Jia Lissa Mar 18, 2026 0

A New Hope from the Ocean Depths: Seaweed’s Potential Against Norovirus In a significant stride for global public health, new…

Read More
Lilly’s plans to buy CAR-T firm Kelonia in deal worth up to $7 billion. Can its deal spree avoid Pfizer’s fate?The Unchanging Blueprint: Evolution’s 120-Million-Year-Old Genetic Cheat Sheet RevealedNovo Nordisk Sues Hims for GLP-1 Patent InfringementThe Grand Tapestry of the Infinitely Large: Richard Elwes’s "Huge Numbers" Explores the Frontiers of Googology
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ